Oral Feeding Intolerance. Malabsorption due to intolerance, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group1: Patients in this group receive the drug Bethanechol. The method of administration is oral. The dose of the drug is calculated based on 0.5 mg per kilogram of body
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Months to 18 Years
Inclusion criteria
Inclusion criteria: Patients aged 1 month to 18 years Admitted to the Pediatric Intensive Care Unit (PICU) Development of feeding intolerance after initiation of oral feeding Absence of reversible causes for feeding intolerance (such as electrolyte imbalance, constipation, or ileus)
Exclusion criteria
Exclusion criteria: Presence of Gastrointestinal bleeding Necrotizing Enterocolitis (NEC) Mechanical bowel obstruction Hirschsprung’s disease Presence of Electrolyte disturbances Presence of Constipation Presence of Ileus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nutritional tolerance. Timepoint: Daily. Method of measurement: Examination of abdominal distension and discharge by physician/evaluator. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects. Timepoint: Every week. Method of measurement: Questioning the patient (or parents) and clinical observation to record symptoms and possible side effects. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Shoja sangchuli
Mashhad University of Medical Sciences
Outcome results
None listed